Abbott Diabetes Care

Entwicklerinformationen

Abbott Diabetes Care wurde im Jahr 2018 gegründet in Vereinigte Staaten. Die erste App wurde am 5. Februar 2018 gestartet und sie haben 62 iOS Apps am March 2025

Abbott Diabetes Care ist ein Herausgeber der App FreeStyle LibreLink – SA und andere Apps in den Kategorien Medical, HealthFitness.

Hauptsitz
Vereinigte Staaten
Gegründet im Jahr
5. Februar 2018
Letzte App-Aktualisierung
vor 1 Monat (28. Januar 2025)

Beliebte Abbott Diabetes Care Apps im Jahr 2025

Vereinigte Staaten
Name
FreeStyle LibreLink – SA
FreeStyle LibreLink – PL
FreeStyle LibreLink – NZ
FreeStyle LibreLink – AU
FreeStyle LibreLink – TR
FreeStyle LibreLink – SE
FreeStyle LibreLink - PT
FreeStyle LibreLink - NO
FreeStyle LibreLink – IE
FreeStyle LibreLink - GR
FreeStyle LibreLink – FI
FreeStyle LibreLink - DK
FreeStyle LibreLink – CH
FreeStyle LibreLink – AT
FreeStyle LibreLink – ES
FreeStyle LibreLink – IT
FreeStyle Libre 3 - CH
FreeStyle Libre 3 - NO
FreeStyle Libre 3 - DE
FreeStyle Libre 3 - GB
FreeStyle Libre 3 - NL
FreeStyle Libre 3 - AT
FreeStyle Libre 3 - BE
FreeStyle Libre 3 - IT
FreeStyle Libre 3 - FR
FreeStyle Libre 3 - SE
FreeStyle Libre 3 - FI
FreeStyle Libre 3 - ES
MyFreeStyle
Your trusted companion
FreeStyle LibreLink – SI
FreeStyle LibreLink – HR
FreeStyle LibreLink – MX
FreeStyle LibreLink – GB
FreeStyle LibreLink – FR
FreeStyle Libre 3 – US
Continuous Glucose Monitoring
FreeStyle Libre 2 - RU
FreeStyle LibreLink – NL
FreeStyle LibreLink – BE
FreeStyle LibreLink – AE
瞬感宝
FreeStyle Libre 2 - US
Flash Glucose Monitoring
FreeStyle LibreLink – CL
FreeStyle LibreLink – BR
FreeStyle LibreLink – TW
FreeStyle LibreLink – HK
FreeStyle LibreLink – SG
FreeStyle LibreLink – IN
FreeStyle LibreLink – ZA
FreeStyle LibreLink – BH
FreeStyle LibreLink – LB
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.